Le deuxième essai majeur pour la thérapie de shunt auriculaire démontre l’importance de la sélection des patients TEWKSBURY, Mass., 12 avril 2024 /PRNewswire/ — Corvia Medical, Inc., une entreprise dédiée à la transformation du traitement de l’insuffisance cardiaque, se réjouit de la…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.